Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.

In addition to the U.S. market release, Nevro introduced the HFX iQ SCS system in select European countries in January 2025 following the receipt of CE Mark Certification in November 2024.

Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro.

The company launched the full market release of HFX iQ with HFX AdaptivAI, a responsive and personalized pain management platform that powers the HFX iQ spinal cord stimulation (SCS) system. In ...

The acquisition of Nevro further expands Globus Medical's presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add to ...

Nevro NVRO is well-poised for growth in the ... The company also received CE Mark Certification in Europe for its HFX iQ SCS system, integrating AI technology to enhance competitiveness and ...